Summary
Work History
Education
Skills
Extracurricular Activities
Languages
Certification
Timeline
Work Availability
Generic
David Lin

David Lin

Business Director - South East Asia
Kuala Lumpur

Summary

As an adept strategist with a proven ability to drive business growth and achieve corporate objectives in the dynamic markets of Malaysia, Singapore, and Brunei, my expertise lies in identifying market access trends and understanding public policy nuances in the Asia Pacific region. This enables me to craft and implement impactful solutions. I possess executive presence and excel in cultivating strong relationships with key stakeholders, including media, government agencies, regulatory bodies, industry groups, key experts, and advocacy think tanks. My passion lies in advancing public policy and enacting significant change through strategic policy advocacy and active engagement in public affairs. Staying abreast of the shifting external affairs landscape is a priority for me as I seek opportunities that foster personal and professional growth within my field. With a comprehensive background as a leader, I bring strong leadership skills and an unwavering drive to enhance public policy. I am poised to be a valuable asset to any organization looking to stimulate substantial growth and expand their market footprint. My consistent track record of delivering exceptional results speaks to my commitment to adding substantial value to collaborative projects and initiatives.

Work History

Business Director

ANSEA Consulting
Kuala Lumpur
09.2024 - Current
  • Provide consultancy works that enables pharmaceuticals, biopharmaceuticals and MedTech companies navigate through complex healthcare systems across the world and helps patients in getting access to their innovative solutions.
  • Expanded market presence by identifying untapped opportunities, conducting competitive analysis, and pursuing strategic acquisitions to enhance the company''s portfolio.

Director, Communications, Government Affairs & Strategic Customer Solutions

GSK
Kuala Lumpur
09.2019 - 08.2024
  • Directed comprehensive operations in Government Affairs, Market Access, Corporate Communications, Strategic Pricing, Tender Business, and Brunei Operations, with a recent focus on spearheading the HIV Business Unit
  • Championed the development of cohesive strategic plans across government affairs, corporate communications, market access, and pricing, leading cross-functional teams to drive organizational goals
  • Crafted and implemented robust external affairs strategies to optimize business conditions, enhance product access, and influence policy reform through targeted stakeholder and media relations
  • Managed all government relations for GSK Malaysia & Brunei, advocating for progressive public, healthcare, and vaccine policies
  • Orchestrated public affairs initiatives and controlled corporate communications, ensuring effective internal and external messaging alignment
  • Served as the principal media spokesperson for GSK Group Malaysia, representing the company's interests and perspectives
  • Proactively pursued market access and pricing opportunities, while rigorously assessing and mitigating associated business risks.

Director, Business Unit, Hospital Specialty Care

MSD
02.2018 - 07.2019
  • Directed P&L objectives for the business unit in Malaysia, Singapore, and Brunei, leading the launch of a new anti-infective product and supporting the ongoing success of new innovative oncology treatment
  • Acted as a key contributor to the Country Leadership Team, influencing high-level strategic initiatives and business direction
  • Achieved P&L targets with USD 30 million in revenue and a profitability rate of 73%, demonstrating strong financial stewardship
  • Led a cross-functional team across market access/policy, regulatory, medical, legal, and compliance sectors to strategically enhance sales revenue for pivotal products including Oncology, Anesthesia, Anti-Infectives, Fertility, and HIV.

Director, Market Access, Policy & Communications

MSD
02.2015 - 02.2018
  • Managed complex access issues and opportunities, overseeing public and vaccines policy, strategic key account management (G2N), and internal/external communications
  • Devised external affairs strategies to sway favourable access and policy decisions, utilizing stakeholder engagement initiatives to advance organizational objectives
  • Led cross-functional teams to develop and execute public affairs and market access roadmaps/plans for enterprise-wide with a particular focus on new oncology and hepatitis C cure asset launches
  • Expedited market access initiatives within the public sector, including MOH National Drug Formulary inclusion, government funding acquisition, and engagement with key stakeholders to gain advocacy.

Head of Market Access

Novartis
07.2013 - 02.2015
  • Pioneered market access and external affairs strategies for the Oncology Business Unit, resulting in expedited approval of favourable pricing and reimbursement for key brands in Malaysia and Brunei
  • Successfully advocated for and secured reimbursement for new product launches, significantly impacting brand performance and patient access
  • Led the integration of health economic tools into pricing negotiations, achieving successful product reimbursement and enhancing market penetration
  • Cultivated strategic partnerships with government and key stakeholders, shaping policies that led to the reimbursement of oncology therapies and a 20% increase in therapy adoption.

Sales & Marketing Manager

Sanofi
06.2010 - 11.2012
  • Directed the Rare Disease Business Unit for Malaysia & Singapore, reporting to the VP & GM of the Sub-Asia Region, overseeing full P&L and operational leadership
  • Pioneered market development for rare diseases treatments and Thyroid Cancer management, established Sanofi's rare disease presence in both countries
  • Championed Market Access initiatives and Government Lobbying, collaborating with cross-functional teams to secure treatment access and funding
  • Orchestrated patient advocacy initiatives, leading the development and management of support programs that empowered patients and raised awareness for rare diseases.

Business Development Manager

Bayer
07.2008 - 05.2010
  • Spearheaded the Diagnostic Imaging Business Unit, demonstrating strategic vision and financial acumen to drive business success
  • Orchestrated marketing strategies for Contrast Media used in X-Ray (CT scan, Angiography) & MRI
  • Championed profitability, skilfully balancing top-line sales with bottom-line expenses for optimal financial health.

Senior Product Manager

Bayer
07.2006 - 06.2008
  • Spearheaded the development and execution of precision marketing strategies, harnessing extensive data analysis for market penetration and informed leadership decisions
  • Conducted rigorous market research, synthesizing data on pricing, demographics, competition, and consumer behavior to shape robust pricing and communication tactics
  • Translated high-level strategic goals into actionable operational plans, utilizing data-driven insights for streamlined implementation and market coherence.

Product Manager

AstraZeneca
03.2005 - 07.2006
  • Conducted comprehensive Market Research and Analysis to remain abreast of evolving market trends, user personas, and competitive landscape, leveraging insights from usage data and customer feedback to guide informed product decisions
  • Developed Strategic Planning initiatives, formulating overarching strategies grounded in meticulous research, while delineating clear market segments, target personas, and innovative product solutions
  • Excelled in Communication, articulating strategic objectives, priorities, and roadmaps with clarity and conviction to stakeholders across the organization, including medical, sales, marketing, and executive teams.

Sales Manager

AstraZeneca
04.2004 - 02.2005
  • Managed key accounts with strategic planning and relationship building, resulting in increased customer loyalty and repeat business.
  • Increased sales revenue by developing and implementing effective sales strategies.

Area Business Manager

Pfizer
07.1999 - 04.2004
  • Conducted regular business reviews with team members, identifying areas for improvement and growth opportunities.
  • Managed a team of sales representatives, providing coaching and guidance to improve performance and achieve targets.

Education

Certificate - Public Policy Analysis

London School of Economics And Political Science
05.2024 - 08.2024

MBA - Business Administration

University of Southern Queensland, Australia
07.2011 - 03.2013

Bachelor of Science - Human Development & Resources Management

Universiti Putra Malaysia
Kuala Lumpur, Malaysia
07.1995 - 03.1999

Skills

Government Affairs

undefined

Extracurricular Activities

Treasurer Board of Directors & Member Board of Directors, Belgium-Luxembourg Chamber of Commerce Malaysia (BeluxCham), Kuala Lumpur, 05/2023, Present, Ensures the integrity of the fiscal affairs of the Chamber | Governs such funds to be kept on deposit in financial institutions or invested in a manner approved by the Board of Directors | Serves on the Board of Directors. Co-Chair of Healthcare & Lifesciences Committee, American Malaysian Chamber of Commerce (AMCHAM), Kuala Lumpur, 09/2023, 08/2024, Co-lead the chamber's advocacy in areas of pharmaceuticals, medical devices, technology, and delivery and to be able to have open discussions on the development and opportunities within these sectors through advocacy and stakeholder engagements. Deputy Chair of Healthcare Committee, British Malaysian Chamber of Commerce (BMCC), Kuala Lumpur, 01/2024, 08/2024, Co-lead chamber's advocacy together with the members, network and have discussions on areas that can advance the healthcare industry in Malaysia. International Society of Pharmacoeconomics and Outcome Research (ISPOR), Mar 2015 - Feb 2019, Abstract reviewer, poster, and podium presentations judge.

Languages

English, Malay
Native language
Chinese (Mandarin)
Intermediate
B1
Chinese (Cantonese)
Upper intermediate
B2

Certification

Public Policy Analysis

Timeline

Public Policy Analysis

09-2024

Business Director

ANSEA Consulting
09.2024 - Current

Certificate - Public Policy Analysis

London School of Economics And Political Science
05.2024 - 08.2024

Director, Communications, Government Affairs & Strategic Customer Solutions

GSK
09.2019 - 08.2024

Director, Business Unit, Hospital Specialty Care

MSD
02.2018 - 07.2019

Director, Market Access, Policy & Communications

MSD
02.2015 - 02.2018

Head of Market Access

Novartis
07.2013 - 02.2015

MBA - Business Administration

University of Southern Queensland, Australia
07.2011 - 03.2013

Sales & Marketing Manager

Sanofi
06.2010 - 11.2012

Business Development Manager

Bayer
07.2008 - 05.2010

Senior Product Manager

Bayer
07.2006 - 06.2008

Product Manager

AstraZeneca
03.2005 - 07.2006

Sales Manager

AstraZeneca
04.2004 - 02.2005

Area Business Manager

Pfizer
07.1999 - 04.2004

Bachelor of Science - Human Development & Resources Management

Universiti Putra Malaysia
07.1995 - 03.1999

Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Similar Profiles

  • Vidhya

    Vidhya Vidhya null

    Research analyst at ANSEA consultancyResearch analyst at ANSEA consultancy

    View Profile
  • PRAVEEN KUMAR

    PRAVEEN KUMARPRAVEEN KUMAR

    Senior Technology Manager at Business Consulting and Solutions, RXG Business Consulting and SolutionsSenior Technology Manager at Business Consulting and Solutions, RXG Business Consulting and Solutions

    View Profile
  • Hanan AlAttas

    Hanan AlAttasHanan AlAttas

    Implementation Consultant at Step Up Consulting / Dan Marqus ConsultingImplementation Consultant at Step Up Consulting / Dan Marqus Consulting

    View Profile
David LinBusiness Director - South East Asia